France· FR:62609613
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 microgrammes/50 microgrammes)/ml, dispersion injectable, Vaccin à ARNm contre la COVID-19
A medicinal product containing imélasoméran + élasoméran, registered in France by MODERNA BIOTECH SPAIN SL (ESPAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IMÉLASOMÉRAN + ÉLASOMÉRAN
- Manufacturer
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093025952810 flacon(s) multidose(s) en verre de 5 dose(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imélasoméran + élasoméran in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandSpikevax bivalent Original/Omicron BA.1MODERNA BIOTECH SPAIN, S.L.
- NetherlandsSpikevax bivalent origineel/omicron BA.1 (25 microgram/25 microgram) dispersie voor injectieModerna Biotech Spain S.L.
- SpainSPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.1 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLEModerna Biotech Spain S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec822a05-ed72-476f-84ef-e7b78af64133 GET /v1/drugs/ec822a05-ed72-476f-84ef-e7b78af64133?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62609613",
"date_amm": "2022-09-01",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1507",
"substance": "IMÉLASOMÉRAN + ÉLASOMÉRAN",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "dispersion injectable",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Oui"
}See everything about imélasoméran + élasoméran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.